Colgate-Palmolive (CL) Financials

$91.96 +0.22 (+0.24%)

As of 05/20/2025 03:59 PM Eastern

Annual Income Statements for Colgate-Palmolive

This table shows Colgate-Palmolive's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	2,889	2,300	1,785	2,166	2,695	2,367	2,400	2,024	2,441	1,384
Consolidated Net Income / (Loss)	3,049	2,455	1,967	2,338	2,860	2,527	2,558	2,174	2,586	1,548
Net Income / (Loss) Continuing Operations	3,049	2,455	1,967	2,338	2,860	2,527	2,558	2,174	2,586	1,548
Total Pre-Tax Income	3,956	3,392	2,660	3,087	3,647	3,301	3,464	3,487	3,738	2,763
Total Operating Income	4,268	3,984	2,893	3,332	3,885	3,554	3,694	3,707	3,955	2,789
Total Gross Profit	12,161	11,326	10,248	10,375	10,017	9,325	9,231	9,280	9,123	9,399
Total Revenue	20,101	19,457	17,967	17,421	16,471	15,693	15,544	15,454	15,195	16,034
Operating Revenue	20,101	19,457	17,967	17,421	16,471	15,693	15,544	15,454	15,195	16,034
Total Cost of Revenue	7,940	8,131	7,719	7,046	6,454	6,368	6,313	6,174	6,072	6,635
Operating Cost of Revenue	7,940	8,131	7,719	7,046	6,454	6,368	6,313	6,174	6,072	6,635
Total Operating Expenses	7,893	7,342	7,355	7,043	6,132	5,771	5,537	5,573	5,168	6,610
Selling, General & Admin Expense	7,729	7,151	6,565	6,407	6,019	5,575	5,389	5,400	5,143	5,464
Other Operating Expenses / (Income)	164	191	69	65	113	196	148	173	25	1,146
Impairment Charge	0.00	0.00	721	571	0.00	0.00	-	-	-	-
Total Other Income / (Expense), net	-312	-592	-233	-245	-238	-253	-230	-220	-217	-26
Interest Expense	292	287	167	175	164	145	143	220	99	26
Interest & Investment Income	67	55	14	-	-	-	-	-	-	-
Other Income / (Expense), net	-87	-360	-80	-70	-74	-108	-87	-	-118	-
Income Tax Expense	907	937	693	749	787	774	906	1,313	1,152	1,215
Net Income / (Loss) Attributable to Noncontrolling Interest	160	155	182	172	165	160	158	150	145	164
Basic Earnings per Share	$3.53	$2.78	$2.13	$2.56	$3.15	$2.76	$2.76	$2.30	$2.74	$1.53
Weighted Average Basic Shares Outstanding	811.54M	823.15M	830.38M	840.49M	848.56M	855.03M	870.60M	881.80M	891.80M	902.20M
Diluted Earnings per Share	$3.51	$2.77	$2.13	$2.55	$3.14	$2.75	$2.75	$2.28	$2.72	$1.52
Weighted Average Diluted Shares Outstanding	811.54M	823.15M	830.38M	840.49M	848.56M	855.03M	870.60M	881.80M	891.80M	902.20M
Weighted Average Basic & Diluted Shares Outstanding	811.54M	823.15M	830.38M	840.49M	848.56M	855.03M	870.60M	881.80M	891.80M	902.20M
Cash Dividends to Common per Share	$2.48	$1.91	$1.86	$1.79	$1.75	$1.71	$1.66	$1.59	-	-

This table shows Colgate-Palmolive's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	690	738	737	731	683	718	708	502	372	5.00	618
Consolidated Net Income / (Loss)	726	777	776	767	729	760	747	534	414	43	682
Net Income / (Loss) Continuing Operations	726	777	776	767	729	760	747	534	414	43	682
Total Pre-Tax Income	953	993	986	1,010	967	988	956	887	561	132	892
Total Operating Income	1,076	1,064	1,065	1,092	1,047	1,072	1,029	974	909	202	947
Total Gross Profit	2,987	2,982	3,074	3,066	3,039	2,950	2,877	2,787	2,712	2,574	2,548
Total Revenue	4,911	4,945	5,033	5,058	5,065	4,950	4,915	4,822	4,770	4,629	4,455
Operating Revenue	4,911	4,945	5,033	5,058	5,065	4,950	4,915	4,822	4,770	4,629	4,455
Total Cost of Revenue	1,924	1,963	1,959	1,992	2,026	2,000	2,038	2,035	2,058	2,055	1,907
Operating Cost of Revenue	1,924	1,963	1,959	1,992	2,026	2,000	2,038	2,035	2,058	2,055	1,907
Total Operating Expenses	1,911	1,918	2,009	1,974	1,992	1,878	1,848	1,813	1,803	2,372	1,601
Selling, General & Admin Expense	1,898	1,895	1,979	1,939	1,916	1,803	1,822	1,768	1,758	1,633	1,634
Other Operating Expenses / (Income)	13	23	30	35	76	75	26	45	45	18	-33
Total Other Income / (Expense), net	-123	-71	-79	-82	-80	-84	-73	-87	-348	-70	-55
Interest Expense	66	189	23	22	58	-	-	29	54	69	40
Interest & Investment Income	15	-	-56	-60	-	-	-58	-58	-	-	-
Other Income / (Expense), net	-72	-	-	-	-22	-	-15	-	-294	-15	-15
Income Tax Expense	227	216	210	243	238	228	209	353	147	89	210
Net Income / (Loss) Attributable to Noncontrolling Interest	36	39	39	36	46	42	39	32	42	38	64
Basic Earnings per Share	$0.85	$0.91	$0.90	$0.89	$0.83	$0.86	$0.86	$0.61	$0.45	-	$0.74
Weighted Average Basic Shares Outstanding	810.42M	811.54M	817.01M	817.09M	820.44M	823.15M	823.37M	826.69M	829.57M	830.38M	835.21M
Diluted Earnings per Share	$0.85	$0.89	$0.90	$0.89	$0.83	$0.86	$0.86	$0.60	$0.45	$0.01	$0.74
Weighted Average Diluted Shares Outstanding	810.42M	811.54M	817.01M	817.09M	820.44M	823.15M	823.37M	826.69M	829.57M	830.38M	835.21M
Weighted Average Basic & Diluted Shares Outstanding	810.42M	811.54M	817.01M	817.09M	820.44M	823.15M	823.37M	826.69M	829.57M	830.38M	835.21M
Cash Dividends to Common per Share	$0.52	-	$0.50	$0.50	$0.98	-	$0.48	$0.48	$0.95	-	$0.47

This table details how cash moves in and out of Colgate-Palmolive's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	130	191	-57	-56	5.00	157	-793	133	345	-119
Net Cash From Operating Activities	4,107	3,745	2,556	3,325	3,719	3,133	3,056	3,054	3,141	2,949
Net Cash From Continuing Operating Activities	4,107	3,745	2,556	3,325	3,719	3,133	3,056	3,054	3,141	2,949
Net Income / (Loss) Continuing Operations	3,049	2,455	1,967	2,338	2,860	2,527	2,558	2,174	2,586	1,548
Consolidated Net Income / (Loss)	3,049	2,455	1,967	2,338	2,860	2,527	2,558	2,174	2,586	1,548
Depreciation Expense	605	567	545	556	539	519	511	475	443	449
Non-Cash Adjustments To Reconcile Net Income	186	366	848	760	59	5.00	115	137	-36	1,125
Changes in Operating Assets and Liabilities, net	267	357	-804	-329	261	82	-128	268	148	-173
Net Cash From Investing Activities	-534	-742	-1,601	-592	-779	-2,099	-1,170	-471	-499	-685
Net Cash From Continuing Investing Activities	-534	-742	-1,601	-592	-779	-2,099	-1,170	-471	-499	-685
Purchase of Property, Plant & Equipment	-561	-705	-696	-567	-410	-335	-436	-553	-593	-691
Acquisitions	0.00	0.00	-809	0.00	-353	-1,711	-728	0.00	-5.00	-13
Purchase of Investments	-574	-506	-470	-141	-143	-184	-169	-347	-336	-742
Sale of Property, Plant & Equipment	0.00	0.00	47	0.00	0.00	-	-	-	60	0.00
Sale and/or Maturity of Investments	564	502	322	141	124	131	156	391	378	599
Other Investing Activities, net	37	-33	5.00	-25	3.00	0.00	7.00	-6.00	-3.00	-68
Net Cash From Financing Activities	-3,389	-2,793	-952	-2,774	-2,919	-870	-2,679	-2,450	-2,233	-2,276
Net Cash From Continuing Financing Activities	-3,389	-2,793	-952	-2,774	-2,919	-870	-2,679	-2,450	-2,233	-2,276
Repayment of Debt	-410	-1,791	116	-898	-564	-1,426	-725	-4,808	-7,274	-9,181
Repurchase of Common Equity	-1,739	-1,128	-1,308	-1,320	-1,476	-1,202	-1,238	-1,399	-1,335	-1,551
Payment of Dividends	-1,789	-1,749	-1,691	-1,679	-1,753	-1,614	-1,591	-1,529	-1,508	-1,493
Issuance of Debt	-89	1,495	1,513	699	0.00	2,874	546	4,779	7,438	9,602
Other Financing Activities, net	638	380	418	424	874	498	329	507	446	347
Effect of Exchange Rate Changes	-54	-19	-60	-15	-16	-7.00	-	-	-64	-107
Cash Interest Paid	302	280	151	194	188	185	194	150	162	131
Cash Income Taxes Paid	933	937	945	890	845	803	847	1,037	932	1,259

This table details how cash moves in and out of Colgate-Palmolive's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	16	-138	124	31	113	15	132	-48	92	-163	80
Net Cash From Operating Activities	600	1,269	1,167	990	681	1,136	1,152	722	735	673	969
Net Cash From Continuing Operating Activities	600	1,269	1,167	990	681	1,136	1,152	722	735	673	969
Net Income / (Loss) Continuing Operations	726	779	775	766	729	760	747	534	414	43	682
Consolidated Net Income / (Loss)	726	779	775	766	729	760	747	534	414	43	682
Depreciation Expense	148	148	150	157	150	150	144	145	128	135	134
Non-Cash Adjustments To Reconcile Net Income	81	24	71	42	49	19	51	22	274	739	-9.00
Changes in Operating Assets and Liabilities, net	-355	318	171	25	-247	207	210	21	-81	-244	162
Net Cash From Investing Activities	-159	-80	-150	-111	-193	-143	-161	-174	-264	-173	-946
Net Cash From Continuing Investing Activities	-159	-80	-150	-111	-193	-143	-161	-174	-264	-173	-946
Purchase of Property, Plant & Equipment	-124	-184	-134	-117	-126	-197	-161	-184	-163	-221	-175
Purchase of Investments	-134	-216	-115	-104	-139	-182	-99	-113	-112	-231	-113
Sale and/or Maturity of Investments	97	304	82	100	78	238	118	132	14	267	20
Other Investing Activities, net	2.00	16	17	10	-6.00	-2.00	-19	-9.00	-3.00	4.00	2.00
Net Cash From Financing Activities	-458	-1,279	-904	-845	-361	-992	-846	-580	-375	-666	99
Net Cash From Continuing Financing Activities	-458	-1,279	-904	-845	-361	-992	-846	-580	-375	-666	99
Repayment of Debt	192	-246	-357	-12	205	-294	-184	109	-1,422	212	-1,066
Repurchase of Common Equity	-284	-455	-295	-480	-509	-245	-332	-371	-180	-413	-104
Payment of Dividends	-406	-514	-408	-473	-394	-506	-396	-457	-390	-485	-392
Issuance of Debt	0.00	-91	-	1.00	1.00	-2.00	-	2.00	1,495	-	1,499
Other Financing Activities, net	40	27	156	119	336	55	66	137	122	20	162
Effect of Exchange Rate Changes	33	-48	11	-3.00	-14	14	-13	-16	-4.00	3.00	-42
Cash Interest Paid	109	35	106	38	123	37	114	35	94	47	39
Cash Income Taxes Paid	139	171	257	355	150	211	276	279	171	255	213

This table presents Colgate-Palmolive's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	16,046	16,393	15,731	15,040	15,920	15,034	12,161	12,676	12,123	11,935
Total Current Assets	5,317	5,279	5,113	4,397	4,338	4,179	3,793	4,639	4,338	4,384
Cash & Equivalents	1,096	966	775	832	888	883	726	1,535	1,315	970
Accounts Receivable	1,521	1,586	1,504	1,297	1,264	1,440	1,400	1,480	1,411	1,427
Inventories, net	1,987	1,934	2,074	1,692	1,673	1,400	1,250	1,221	1,171	1,180
Other Current Assets	713	793	760	576	513	456	417	403	441	807
Plant, Property, & Equipment, net	4,422	4,582	4,307	3,730	3,716	3,750	3,881	4,072	3,840	3,796
Total Noncurrent Assets	6,307	6,532	6,311	6,913	7,866	7,105	4,487	3,965	3,945	3,755
Goodwill	3,272	3,410	3,352	3,284	3,824	3,508	2,530	2,218	2,107	2,103
Intangible Assets	1,756	1,887	1,920	2,462	2,894	2,667	1,637	1,341	1,313	1,346
Noncurrent Deferred & Refundable Income Taxes	195	214	135	193	291	177	152	188	301	67
Other Noncurrent Operating Assets	1,084	1,021	904	974	857	753	168	218	224	239
Total Liabilities & Shareholders' Equity	16,046	16,393	15,731	15,040	15,920	15,034	12,161	12,676	12,123	11,935
Total Liabilities	15,502	15,436	14,925	14,069	14,819	14,476	11,964	12,433	12,106	11,979
Total Current Liabilities	5,759	4,741	4,004	4,051	4,404	4,038	3,341	3,408	3,305	3,534
Short-Term Debt	660	330	25	51	267	514	12	11	13	302
Accounts Payable	1,805	1,698	1,551	1,479	1,393	1,237	1,222	1,212	1,124	1,110
Accrued Expenses	2,891	2,377	2,111	2,085	2,341	1,917	1,696	1,831	1,727	1,845
Current Deferred & Payable Income Tax Liabilities	403	336	317	436	403	370	411	354	441	277
Total Noncurrent Liabilities	9,743	10,695	10,921	10,018	10,415	10,438	8,623	9,025	8,801	8,445
Long-Term Debt	7,289	8,219	8,741	7,194	7,334	7,333	6,354	6,566	6,520	6,246
Noncurrent Deferred & Payable Income Tax Liabilities	343	361	383	395	426	507	235	204	246	233
Other Noncurrent Operating Liabilities	2,111	2,115	1,797	2,429	2,655	2,598	2,034	2,255	2,035	1,966
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	544	957	806	971	1,101	558	197	243	17	-44
Total Preferred & Common Equity	212	609	401	609	743	117	-102	-60	-243	-299
Total Common Equity	212	609	401	609	743	117	-102	-60	-243	-299
Common Stock	5,647	5,274	5,012	4,735	4,435	3,954	3,670	3,450	3,157	2,904
Retained Earnings	26,145	25,289	24,573	24,350	23,699	22,501	21,615	20,531	19,922	18,861
Treasury Stock	-27,358	-26,017	-25,128	-24,089	-23,045	-22,063	-21,196	-20,181	-19,135	-18,102
Accumulated Other Comprehensive Income / (Loss)	-4,222	-3,937	-4,055	-4,386	-4,345	-4,273	-4,188	-3,855	-4,180	-3,950
Noncontrolling Interest	332	348	405	362	358	441	299	303	260	255

This table presents Colgate-Palmolive's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Total Assets	16,647	16,046	16,774	16,480	16,571	16,393	16,043	16,227	16,173	15,731	16,288
Total Current Assets	5,814	5,317	5,806	5,646	5,640	5,279	5,357	5,437	5,466	5,113	5,278
Cash & Equivalents	1,112	1,096	1,234	1,110	1,079	966	951	819	867	775	938
Accounts Receivable	1,725	1,521	1,712	1,825	1,813	1,586	1,577	1,656	1,590	1,504	1,425
Inventories, net	2,125	1,987	2,041	1,922	1,914	1,934	1,931	2,039	2,110	2,074	2,073
Other Current Assets	852	713	819	789	834	793	898	923	899	760	842
Plant, Property, & Equipment, net	4,416	4,422	4,421	4,392	4,497	4,582	4,409	4,431	4,363	4,307	4,123
Plant, Property & Equipment, gross	10,276	-	10,238	10,167	10,261	-	9,979	9,988	9,815	-	9,318
Accumulated Depreciation	5,860	-	5,817	5,775	5,764	-	5,570	5,557	5,452	-	5,195
Total Noncurrent Assets	6,417	6,307	6,547	6,442	6,434	6,532	6,277	6,359	6,344	6,311	6,887
Goodwill	3,334	3,272	3,389	3,320	3,341	3,410	3,327	3,373	3,375	3,352	3,538
Intangible Assets	1,782	1,756	1,834	1,814	1,837	1,887	1,861	1,901	1,918	1,920	2,219
Noncurrent Deferred & Refundable Income Taxes	211	195	219	214	222	214	202	186	179	135	182
Other Noncurrent Operating Assets	1,090	1,084	1,105	1,094	1,034	1,021	887	899	872	904	948
Total Liabilities & Shareholders' Equity	16,647	16,046	16,774	16,480	16,571	16,393	16,043	16,227	16,173	15,731	16,288
Total Liabilities	15,914	15,502	15,938	15,998	15,954	15,436	15,637	15,912	15,748	14,925	15,235
Total Current Liabilities	6,861	5,759	5,565	5,350	5,314	4,741	4,602	4,632	4,441	4,004	4,492
Short-Term Debt	1,698	660	527	530	538	330	34	35	37	25	29
Accounts Payable	1,800	1,805	1,625	1,557	1,646	1,698	1,482	1,544	1,609	1,551	1,541
Accrued Expenses	2,873	2,891	3,066	2,864	2,720	2,377	2,732	2,600	2,498	2,111	2,489
Current Deferred & Payable Income Tax Liabilities	490	403	347	399	410	336	354	453	297	317	433
Total Noncurrent Liabilities	9,053	9,743	10,373	10,648	10,640	10,695	11,035	11,280	11,307	10,921	10,743
Long-Term Debt	6,571	7,289	7,909	8,146	8,151	8,219	8,690	8,954	8,870	8,741	8,219
Noncurrent Deferred & Payable Income Tax Liabilities	302	343	320	355	392	361	430	363	421	383	551
Other Noncurrent Operating Liabilities	2,180	2,111	2,144	2,147	2,097	2,115	1,915	1,963	2,016	1,797	1,973
Total Equity & Noncontrolling Interests	733	544	836	482	617	957	406	315	425	806	1,053
Total Preferred & Common Equity	363	212	435	123	230	609	-9.00	-64	-6.00	401	622
Total Common Equity	363	212	435	123	230	609	-9.00	-64	-6.00	401	622
Common Stock	5,668	5,647	5,608	5,501	5,428	5,274	5,228	5,154	5,069	5,012	4,984
Retained Earnings	26,413	26,145	25,814	25,486	25,164	25,289	24,571	24,258	24,153	24,573	24,566
Treasury Stock	-27,602	-27,358	-26,913	-26,736	-26,343	-26,017	-25,834	-25,541	-25,245	-25,128	-24,749
Accumulated Other Comprehensive Income / (Loss)	-4,116	-4,222	-4,074	-4,128	-4,019	-3,937	-3,974	-3,935	-3,983	-4,055	-4,179
Noncontrolling Interest	370	332	401	359	387	348	415	379	431	405	431

This table displays calculated financial ratios and metrics derived from Colgate-Palmolive's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	3.31%	8.29%	3.13%	5.77%	4.96%	0.96%	0.58%	1.70%	-5.23%	-7.19%
EBITDA Growth	14.20%	24.81%	-12.05%	-12.23%	9.71%	-3.72%	-1.53%	-2.29%	32.18%	-19.03%
EBIT Growth	15.37%	28.83%	-13.76%	-14.41%	10.59%	-4.46%	-2.70%	-3.39%	37.58%	-21.59%
NOPAT Growth	14.08%	34.79%	-15.23%	-17.17%	11.98%	-0.26%	18.03%	-15.53%	75.10%	-33.65%
Net Income Growth	24.20%	24.81%	-15.87%	-18.25%	13.18%	-1.21%	17.66%	-15.93%	67.05%	-33.82%
EPS Growth	26.71%	30.05%	-16.47%	-18.79%	14.18%	0.00%	20.61%	-16.18%	78.95%	-35.59%
Operating Cash Flow Growth	9.67%	46.52%	-23.13%	-10.59%	18.70%	2.52%	0.07%	-2.77%	6.51%	-10.58%
Free Cash Flow Firm Growth	41.14%	332.39%	-75.41%	7.22%	165.97%	-52.40%	-3.77%	-25.50%	22.75%	-21.30%
Invested Capital Growth	-13.38%	-2.92%	19.14%	-5.50%	3.88%	28.87%	10.44%	0.96%	-5.40%	-14.12%
Revenue Q/Q Growth	-0.02%	1.68%	1.27%	0.46%	1.91%	1.32%	-0.52%	1.12%	-1.16%	-1.97%
EBITDA Q/Q Growth	-1.99%	14.32%	-4.74%	-14.95%	-0.68%	-1.52%	-3.54%	-2.47%	34.42%	-25.95%
EBIT Q/Q Growth	-2.22%	16.38%	-5.38%	-17.12%	-0.94%	-1.94%	-4.15%	-2.96%	39.88%	-28.91%
NOPAT Q/Q Growth	0.25%	35.11%	-5.47%	-17.50%	0.68%	1.54%	12.76%	-12.92%	72.50%	-41.05%
Net Income Q/Q Growth	0.56%	41.25%	-6.87%	-17.73%	0.35%	1.57%	12.79%	-11.23%	68.25%	-41.25%
EPS Q/Q Growth	0.86%	44.27%	-6.99%	-18.79%	0.32%	1.85%	13.64%	-11.97%	76.62%	-44.73%
Operating Cash Flow Q/Q Growth	3.35%	14.11%	-14.49%	4.49%	-0.19%	3.57%	3.49%	-2.08%	-0.54%	-2.16%
Free Cash Flow Firm Q/Q Growth	29.51%	35.47%	-56.38%	13.00%	-10.66%	3.84%	1.77%	-16.03%	46.76%	-21.79%
Invested Capital Q/Q Growth	-7.97%	4.41%	5.19%	-4.91%	6.75%	1.97%	2.49%	-2.38%	-4.00%	-6.76%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	60.50%	58.21%	57.04%	59.55%	60.82%	59.42%	59.39%	60.05%	60.04%	58.62%
EBITDA Margin	23.81%	21.54%	18.69%	21.92%	26.41%	25.27%	26.49%	27.06%	28.17%	20.19%
Operating Margin	21.23%	20.48%	16.10%	19.13%	23.59%	22.65%	23.76%	23.99%	26.03%	17.39%
EBIT Margin	20.80%	18.63%	15.66%	18.72%	23.14%	21.96%	23.21%	23.99%	25.25%	17.39%
Profit (Net Income) Margin	15.17%	12.62%	10.95%	13.42%	17.36%	16.10%	16.46%	14.07%	17.02%	9.65%
Tax Burden Percent	77.07%	72.38%	73.95%	75.74%	78.42%	76.55%	73.85%	62.35%	69.18%	56.03%
Interest Burden Percent	94.62%	93.60%	94.56%	94.64%	95.70%	95.79%	96.04%	94.07%	97.42%	99.07%
Effective Tax Rate	22.93%	27.62%	26.05%	24.26%	21.58%	23.45%	26.15%	37.65%	30.82%	43.97%
Return on Invested Capital (ROIC)	41.28%	33.26%	26.44%	33.21%	39.73%	40.73%	49.05%	43.94%	50.81%	26.09%
ROIC Less NNEP Spread (ROIC-NNEP)	37.95%	27.76%	24.05%	30.38%	37.00%	37.66%	45.87%	41.26%	48.03%	25.82%
Return on Net Nonoperating Assets (RNNOA)	364.98%	245.24%	194.94%	192.47%	305.05%	628.67%	1,113.67%	1,628.37%	-19,206.37%	204.78%
Return on Equity (ROE)	406.26%	278.50%	221.38%	225.68%	344.79%	669.40%	1,162.73%	1,672.31%	-19,155.56%	230.87%
Cash Return on Invested Capital (CROIC)	55.62%	36.23%	8.98%	38.87%	35.92%	15.51%	39.13%	42.99%	56.37%	41.29%
Operating Return on Assets (OROA)	25.78%	22.56%	18.28%	21.07%	24.62%	25.34%	29.05%	29.90%	31.90%	21.97%
Return on Assets (ROA)	18.80%	15.28%	12.78%	15.10%	18.48%	18.58%	20.60%	17.53%	21.50%	12.19%
Return on Common Equity (ROCE)	222.21%	159.55%	125.83%	147.26%	178.73%	13.30%	-428.10%	-1,948.88%	-384,530.04%	145.65%
Return on Equity Simple (ROE_SIMPLE)	1,438.21%	403.12%	490.52%	383.91%	384.93%	2,159.83%	-2,507.84%	-3,623.33%	-1,064.20%	-517.73%
Net Operating Profit after Tax (NOPAT)	3,289	2,883	2,139	2,524	3,047	2,721	2,728	2,311	2,736	1,563
NOPAT Margin	16.36%	14.82%	11.91%	14.49%	18.50%	17.34%	17.55%	14.96%	18.01%	9.75%
Net Nonoperating Expense Percent (NNEP)	3.33%	5.50%	2.39%	2.83%	2.73%	3.07%	3.18%	2.67%	2.78%	0.27%
Return On Investment Capital (ROIC_SIMPLE)	38.73%	30.33%	22.35%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	39.50%	41.79%	42.96%	40.45%	39.18%	40.58%	40.61%	39.95%	39.96%	41.38%
SG&A Expenses to Revenue	38.45%	36.75%	36.54%	36.78%	36.54%	35.53%	34.67%	34.94%	33.85%	34.08%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	39.27%	37.73%	40.94%	40.43%	37.23%	36.77%	35.62%	36.06%	34.01%	41.22%
Earnings before Interest and Taxes (EBIT)	4,181	3,624	2,813	3,262	3,811	3,446	3,607	3,707	3,837	2,789
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	4,786	4,191	3,358	3,818	4,350	3,965	4,118	4,182	4,280	3,238
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	348.38	104.85	155.64	111.74	91.25	455.60	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	3.67	3.28	3.47	3.91	4.12	3.40	2.93	3.69	3.22	3.07
Price to Earnings (P/E)	25.56	27.76	34.96	31.42	25.16	22.52	18.95	28.16	20.05	35.52
Dividend Yield	2.19%	2.46%	2.49%	2.22%	2.21%	2.75%	3.17%	2.45%	2.82%	2.74%
Earnings Yield	3.91%	3.60%	2.86%	3.18%	3.98%	4.44%	5.28%	3.55%	4.99%	2.82%
Enterprise Value to Invested Capital (EV/IC)	10.96	8.41	8.05	10.13	9.58	8.07	8.81	11.79	10.39	9.94
Enterprise Value to Revenue (EV/Rev)	4.03	3.69	3.94	4.30	4.55	3.87	3.31	4.03	3.58	3.43
Enterprise Value to EBITDA (EV/EBITDA)	16.93	17.13	21.09	19.60	17.21	15.31	12.49	14.91	12.71	16.98
Enterprise Value to EBIT (EV/EBIT)	19.38	19.81	25.17	22.94	19.65	17.62	14.26	16.82	14.18	19.72
Enterprise Value to NOPAT (EV/NOPAT)	24.64	24.90	33.10	29.65	24.57	22.31	18.85	26.97	19.89	35.20
Enterprise Value to Operating Cash Flow (EV/OCF)	19.73	19.17	27.70	22.50	20.13	19.38	16.83	20.41	17.32	18.65
Enterprise Value to Free Cash Flow (EV/FCFF)	18.28	22.86	97.49	25.33	27.18	58.62	23.63	27.57	17.93	22.24
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	14.61	8.93	10.88	7.46	6.90	14.06	32.31	27.07	384.29	-148.82
Long-Term Debt to Equity	13.40	8.59	10.84	7.41	6.66	13.14	32.25	27.02	383.53	-141.95
Financial Leverage	9.62	8.83	8.11	6.33	8.24	16.69	24.28	39.46	-399.85	7.93
Leverage Ratio	21.61	18.22	17.32	14.94	18.66	36.02	56.45	95.38	-891.04	18.94
Compound Leverage Factor	20.45	17.05	16.37	14.14	17.86	34.50	54.21	89.72	-868.05	18.76
Debt to Total Capital	93.59%	89.93%	91.58%	88.18%	87.35%	93.36%	97.00%	96.44%	99.74%	100.68%
Short-Term Debt to Total Capital	7.77%	3.47%	0.26%	0.62%	3.07%	6.12%	0.18%	0.16%	0.20%	4.64%
Long-Term Debt to Total Capital	85.82%	86.46%	91.32%	87.56%	84.28%	87.25%	96.82%	96.28%	99.54%	96.03%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	3.91%	3.66%	4.23%	4.41%	4.11%	5.25%	4.56%	4.44%	3.97%	3.92%
Common Equity to Total Capital	2.50%	6.41%	4.19%	7.41%	8.54%	1.39%	-1.55%	-0.88%	-3.71%	-4.60%
Debt to EBITDA	1.66	2.04	2.61	1.90	1.75	1.98	1.55	1.57	1.53	2.02
Net Debt to EBITDA	1.43	1.81	2.38	1.68	1.54	1.76	1.37	1.21	1.22	1.72
Long-Term Debt to EBITDA	1.52	1.96	2.60	1.88	1.69	1.85	1.54	1.57	1.52	1.93
Debt to NOPAT	2.42	2.96	4.10	2.87	2.49	2.88	2.33	2.85	2.39	4.19
Net Debt to NOPAT	2.08	2.63	3.74	2.54	2.20	2.56	2.07	2.18	1.91	3.57
Long-Term Debt to NOPAT	2.22	2.85	4.09	2.85	2.41	2.70	2.33	2.84	2.38	4.00
Altman Z-Score	7.22	6.60	6.51	7.07	6.65	6.12	7.07	7.32	7.13	6.87
Noncontrolling Interest Sharing Ratio	45.30%	42.71%	43.16%	34.75%	48.16%	98.01%	136.82%	216.54%	-1,907.41%	36.91%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.92	1.11	1.28	1.09	0.99	1.03	1.14	1.36	1.31	1.24
Quick Ratio	0.45	0.54	0.57	0.53	0.49	0.58	0.64	0.88	0.82	0.68
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	4,432	3,140	726	2,954	2,755	1,036	2,176	2,261	3,035	2,473
Operating Cash Flow to CapEx	732.09%	531.21%	393.84%	586.42%	907.07%	935.22%	700.92%	552.26%	589.31%	426.77%
Free Cash Flow to Firm to Interest Expense	15.18	10.94	4.35	16.88	16.80	7.14	15.22	10.28	30.66	95.10
Operating Cash Flow to Interest Expense	14.07	13.05	15.31	19.00	22.68	21.61	21.37	13.88	31.73	113.42
Operating Cash Flow Less CapEx to Interest Expense	12.14	10.59	11.42	15.76	20.18	19.30	18.32	11.37	26.34	86.85
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.24	1.21	1.17	1.13	1.06	1.15	1.25	1.25	1.26	1.26
Accounts Receivable Turnover	12.94	12.59	12.83	13.60	12.18	11.05	10.79	10.69	10.71	10.76
Inventory Turnover	4.05	4.06	4.10	4.19	4.20	4.81	5.11	5.16	5.17	5.18
Fixed Asset Turnover	4.46	4.38	4.47	4.68	4.41	4.11	3.91	3.91	3.98	4.07
Accounts Payable Turnover	4.53	5.01	5.10	4.91	4.91	5.18	5.19	5.29	5.44	5.67
Days Sales Outstanding (DSO)	28.21	28.98	28.45	26.83	29.96	33.03	33.81	34.14	34.09	33.91
Days Inventory Outstanding (DIO)	90.12	89.96	89.04	87.16	86.90	75.95	71.43	70.71	70.66	70.47
Days Payable Outstanding (DPO)	80.52	72.92	71.64	74.39	74.37	70.47	70.36	69.05	67.15	64.39
Cash Conversion Cycle (CCC)	37.82	46.02	45.85	39.60	42.49	38.50	34.88	35.80	37.60	39.99
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	7,397	8,540	8,797	7,384	7,814	7,522	5,837	5,285	5,235	5,534
Invested Capital Turnover	2.52	2.24	2.22	2.29	2.15	2.35	2.80	2.94	2.82	2.68
Increase / (Decrease) in Invested Capital	-1,143	-257	1,413	-430	292	1,685	552	50	-299	-910
Enterprise Value (EV)	81,041	71,784	70,806	74,828	74,869	60,710	51,425	62,334	54,412	54,996
Market Capitalization	73,856	63,853	62,410	68,053	67,798	53,305	45,486	56,989	48,934	49,163
Book Value per Share	$0.26	$0.74	$0.48	$0.72	$0.87	$0.14	($0.12)	($0.07)	($0.27)	($0.33)
Tangible Book Value per Share	($5.89)	($5.69)	($5.83)	($6.09)	($6.97)	($7.07)	($4.92)	($4.12)	($4.12)	($4.18)
Total Capital	8,493	9,506	9,572	8,216	8,702	8,405	6,563	6,820	6,550	6,504
Total Debt	7,949	8,549	8,766	7,245	7,601	7,847	6,366	6,577	6,533	6,548
Total Long-Term Debt	7,289	8,219	8,741	7,194	7,334	7,333	6,354	6,566	6,520	6,246
Net Debt	6,853	7,583	7,991	6,413	6,713	6,964	5,640	5,042	5,218	5,578
Capital Expenditures (CapEx)	561	705	649	567	410	335	436	553	533	691
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-878	-98	359	-435	-687	-228	-262	-293	-269	182
Debt-free Net Working Capital (DFNWC)	218	868	1,134	397	201	655	464	1,242	1,046	1,152
Net Working Capital (NWC)	-442	538	1,109	346	-66	141	452	1,231	1,033	850
Net Nonoperating Expense (NNE)	240	428	172	186	187	194	170	137	150	15
Net Nonoperating Obligations (NNO)	6,853	7,583	7,991	6,413	6,713	6,964	5,640	5,042	5,218	5,578
Total Depreciation and Amortization (D&A)	605	567	545	556	539	519	511	475	443	449
Debt-free, Cash-free Net Working Capital to Revenue	-4.37%	-0.50%	2.00%	-2.50%	-4.17%	-1.45%	-1.69%	-1.90%	-1.77%	1.14%
Debt-free Net Working Capital to Revenue	1.08%	4.46%	6.31%	2.28%	1.22%	4.17%	2.99%	8.04%	6.88%	7.18%
Net Working Capital to Revenue	-2.20%	2.77%	6.17%	1.99%	-0.40%	0.90%	2.91%	7.97%	6.80%	5.30%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.53	$2.78	$2.13	$2.56	$3.15	$2.76	$2.76	$0.00	$2.74	$1.53
Adjusted Weighted Average Basic Shares Outstanding	811.54M	823.15M	830.38M	840.49M	848.56M	855.03M	861.68M	0.00	882.86M	892.74M
Adjusted Diluted Earnings per Share	$3.51	$2.77	$2.13	$2.55	$3.14	$2.75	$2.75	$0.00	$2.72	$1.52
Adjusted Weighted Average Diluted Shares Outstanding	811.54M	823.15M	830.38M	840.49M	848.56M	855.03M	861.68M	0.00	882.86M	892.74M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	811.54M	823.15M	830.38M	840.49M	848.56M	855.03M	861.68M	0.00	882.86M	892.74M
Normalized Net Operating Profit after Tax (NOPAT)	3,289	2,883	2,672	2,956	3,047	2,721	2,728	2,311	2,736	1,563
Normalized NOPAT Margin	16.36%	14.82%	14.87%	16.97%	18.50%	17.34%	17.55%	14.96%	18.01%	9.75%
Pre Tax Income Margin	19.68%	17.43%	14.80%	17.72%	22.14%	21.03%	22.29%	22.56%	24.60%	17.23%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	14.32	12.63	16.84	18.64	23.24	23.77	25.22	16.85	38.76	107.27
NOPAT to Interest Expense	11.27	10.05	12.81	14.42	18.58	18.76	19.08	10.51	27.64	60.10
EBIT Less CapEx to Interest Expense	12.40	10.17	12.96	15.40	20.74	21.46	22.17	14.34	33.37	80.69
NOPAT Less CapEx to Interest Expense	9.34	7.59	8.92	11.18	16.08	16.45	16.03	7.99	22.25	33.52
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	58.68%	71.24%	85.97%	71.81%	61.29%	63.87%	62.20%	70.33%	58.31%	96.45%
Augmented Payout Ratio	115.71%	117.19%	152.47%	128.27%	112.90%	111.44%	110.59%	134.68%	109.94%	196.64%

This table displays calculated financial ratios and metrics derived from Colgate-Palmolive's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-3.04%	-0.10%	2.40%	4.89%	6.18%	6.93%	10.33%	7.54%	8.43%	5.13%	0.93%
EBITDA Growth	-1.96%	-0.82%	4.92%	11.62%	58.14%	279.50%	8.63%	10.79%	-22.60%	-34.15%	-2.29%
EBIT Growth	-2.05%	-0.75%	5.03%	12.12%	66.67%	473.26%	8.80%	11.70%	-25.18%	-46.11%	-2.00%
NOPAT Growth	3.85%	0.96%	4.25%	41.42%	17.66%	1,153.16%	11.05%	-12.70%	2.84%	-68.93%	-6.21%
Net Income Growth	-0.41%	2.24%	3.88%	43.63%	76.09%	1,667.44%	9.53%	-16.43%	-31.34%	-77.13%	0.15%
EPS Growth	2.41%	3.49%	4.65%	48.33%	84.44%	8,500.00%	16.22%	-16.67%	-31.82%	-94.12%	-1.33%
Operating Cash Flow Growth	-11.89%	11.71%	1.30%	37.12%	-7.35%	68.80%	18.89%	36.74%	90.41%	-39.15%	-2.52%
Free Cash Flow Firm Growth	12.60%	82.65%	-0.90%	695.55%	405.58%	180.29%	683.84%	-124.25%	-148.35%	-309.91%	-61.45%
Invested Capital Growth	-4.10%	-13.38%	-1.72%	-5.15%	-2.81%	-2.92%	-2.20%	10.40%	13.50%	19.14%	7.70%
Revenue Q/Q Growth	-0.69%	-1.75%	-0.49%	-0.14%	2.32%	0.71%	1.93%	1.09%	3.05%	3.91%	-0.65%
EBITDA Q/Q Growth	-4.95%	-0.25%	-2.72%	6.30%	-2.08%	5.53%	3.49%	50.61%	130.75%	-69.79%	5.54%
EBIT Q/Q Growth	-5.64%	-0.09%	-2.47%	6.54%	-2.38%	5.72%	4.11%	58.37%	228.88%	-79.94%	6.88%
NOPAT Q/Q Growth	-1.54%	-0.67%	1.07%	5.06%	-4.28%	2.56%	37.12%	-12.59%	919.43%	-90.91%	7.80%
Net Income Q/Q Growth	-6.56%	0.13%	1.17%	5.21%	-4.08%	1.74%	39.89%	28.99%	862.79%	-93.70%	6.73%
EPS Q/Q Growth	-4.49%	-1.11%	1.12%	7.23%	-3.49%	0.00%	43.33%	33.33%	4,400.00%	-98.65%	2.78%
Operating Cash Flow Q/Q Growth	-52.72%	8.74%	17.88%	45.37%	-40.05%	-1.39%	59.56%	-1.77%	9.21%	-30.55%	83.52%
Free Cash Flow Firm Q/Q Growth	-41.45%	101.76%	-22.67%	23.26%	-5.02%	9.47%	564.69%	36.75%	75.05%	-1,168.77%	-85.62%
Invested Capital Q/Q Growth	6.66%	-7.97%	-0.12%	-2.18%	-3.67%	4.41%	-3.61%	0.24%	-3.77%	5.19%	8.81%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	60.82%	60.30%	61.08%	60.62%	60.00%	59.60%	58.54%	57.80%	56.86%	55.61%	57.19%
EBITDA Margin	23.46%	24.51%	24.14%	24.69%	23.20%	24.69%	23.56%	23.21%	15.58%	6.96%	23.93%
Operating Margin	21.91%	21.52%	21.16%	21.59%	20.67%	21.66%	20.94%	20.20%	19.06%	4.36%	21.26%
EBIT Margin	20.44%	21.52%	21.16%	21.59%	20.24%	21.66%	20.63%	20.20%	12.89%	4.04%	20.92%
Profit (Net Income) Margin	14.78%	15.71%	15.42%	15.16%	14.39%	15.35%	15.20%	11.07%	8.68%	0.93%	15.31%
Tax Burden Percent	76.18%	78.25%	78.70%	75.94%	75.39%	76.92%	78.14%	60.20%	73.80%	32.58%	76.46%
Interest Burden Percent	94.92%	93.33%	92.58%	92.49%	94.34%	92.16%	94.28%	91.07%	91.22%	70.59%	95.71%
Effective Tax Rate	23.82%	21.75%	21.30%	24.06%	24.61%	23.08%	21.86%	39.80%	26.20%	67.42%	23.54%
Return on Invested Capital (ROIC)	41.32%	42.47%	41.29%	39.64%	36.88%	37.39%	37.85%	28.09%	32.39%	3.16%	35.76%
ROIC Less NNEP Spread (ROIC-NNEP)	40.05%	41.70%	40.46%	38.85%	36.11%	36.56%	37.09%	27.40%	28.91%	2.84%	35.16%
Return on Net Nonoperating Assets (RNNOA)	438.04%	401.06%	487.88%	767.08%	542.34%	322.98%	383.45%	480.21%	370.40%	23.02%	237.45%
Return on Equity (ROE)	479.36%	443.53%	529.18%	806.73%	579.23%	360.38%	421.30%	508.30%	402.79%	26.18%	273.20%
Cash Return on Invested Capital (CROIC)	45.38%	55.62%	42.21%	44.57%	38.87%	36.23%	28.03%	15.50%	14.43%	8.98%	20.65%
Operating Return on Assets (OROA)	24.55%	26.67%	25.93%	26.39%	24.41%	26.23%	24.42%	23.62%	14.83%	4.72%	23.08%
Return on Assets (ROA)	17.75%	19.47%	18.89%	18.53%	17.36%	18.60%	17.99%	12.95%	9.98%	1.08%	16.89%
Return on Common Equity (ROCE)	210.56%	242.60%	181.51%	59.72%	124.52%	206.45%	177.01%	60.55%	110.04%	14.88%	159.32%
Return on Equity Simple (ROE_SIMPLE)	839.12%	0.00%	697.01%	2,441.46%	1,204.35%	0.00%	0.00%	-2,614.06%	0.00%	0.00%	339.55%
Net Operating Profit after Tax (NOPAT)	820	833	838	829	789	825	804	586	671	66	724
NOPAT Margin	16.69%	16.84%	16.65%	16.40%	15.58%	16.66%	16.36%	12.16%	14.06%	1.42%	16.25%
Net Nonoperating Expense Percent (NNEP)	1.27%	0.77%	0.83%	0.79%	0.77%	0.83%	0.76%	0.68%	3.48%	0.32%	0.60%
Return On Investment Capital (ROIC_SIMPLE)	9.11%	9.80%	-	-	-	8.67%	-	-	-	0.69%	-
Cost of Revenue to Revenue	39.18%	39.70%	38.92%	39.38%	40.00%	40.40%	41.46%	42.20%	43.14%	44.39%	42.81%
SG&A Expenses to Revenue	38.65%	38.32%	39.32%	38.34%	37.83%	36.42%	37.07%	36.67%	36.86%	35.28%	36.68%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	38.91%	38.79%	39.92%	39.03%	39.33%	37.94%	37.60%	37.60%	37.80%	51.24%	35.94%
Earnings before Interest and Taxes (EBIT)	1,004	1,064	1,065	1,092	1,025	1,072	1,014	974	615	187	932
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1,152	1,212	1,215	1,249	1,175	1,222	1,158	1,119	743	322	1,066
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	208.31	348.38	194.02	644.00	320.51	104.85	0.00	0.00	0.00	155.64	90.69
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	3.79	3.67	4.20	3.96	3.73	3.28	2.99	3.32	3.30	3.47	3.18
Price to Earnings (P/E)	26.11	25.56	29.42	27.89	28.23	27.76	36.01	41.44	37.86	34.96	29.26
Dividend Yield	2.15%	2.19%	1.90%	2.01%	2.14%	2.46%	2.75%	2.53%	2.58%	2.49%	2.72%
Earnings Yield	3.83%	3.91%	3.40%	3.59%	3.54%	3.60%	2.78%	2.41%	2.64%	2.86%	3.42%
Enterprise Value to Invested Capital (EV/IC)	10.54	10.96	11.45	10.83	9.93	8.41	7.99	8.32	8.15	8.05	7.67
Enterprise Value to Revenue (EV/Rev)	4.17	4.03	4.58	4.36	4.14	3.69	3.41	3.78	3.76	3.94	3.62
Enterprise Value to EBITDA (EV/EBITDA)	17.46	16.93	18.84	18.00	17.68	17.13	17.82	19.75	21.96	21.09	18.20
Enterprise Value to EBIT (EV/EBIT)	19.99	19.38	21.52	20.55	20.26	19.81	20.98	23.28	26.47	25.17	21.58
Enterprise Value to NOPAT (EV/NOPAT)	25.04	24.64	28.04	26.83	27.18	24.90	30.61	34.40	31.99	33.10	28.35
Enterprise Value to Operating Cash Flow (EV/OCF)	20.65	19.73	23.15	22.01	22.14	19.17	19.91	22.78	23.74	27.70	21.46
Enterprise Value to Free Cash Flow (EV/FCFF)	22.73	18.28	26.88	23.65	25.19	22.86	28.18	56.34	60.02	97.49	38.53
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	11.28	14.61	10.09	18.00	14.08	8.93	21.49	28.54	20.96	10.88	7.83
Long-Term Debt to Equity	8.96	13.40	9.46	16.90	13.21	8.59	21.40	28.43	20.87	10.84	7.81
Financial Leverage	10.94	9.62	12.06	19.74	15.02	8.83	10.34	17.52	12.81	8.11	6.75
Leverage Ratio	24.61	21.61	26.42	41.04	31.42	18.22	22.16	36.58	27.66	17.32	15.47
Compound Leverage Factor	23.36	20.17	24.46	37.96	29.65	16.79	20.89	33.32	25.23	12.22	14.80
Debt to Total Capital	91.86%	93.59%	90.98%	94.74%	93.37%	89.93%	95.55%	96.61%	95.45%	91.58%	88.68%
Short-Term Debt to Total Capital	18.86%	7.77%	5.68%	5.79%	5.78%	3.47%	0.37%	0.38%	0.40%	0.26%	0.31%
Long-Term Debt to Total Capital	72.99%	85.82%	85.30%	88.95%	87.59%	86.46%	95.18%	96.24%	95.05%	91.32%	88.37%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	4.11%	3.91%	4.32%	3.92%	4.16%	3.66%	4.55%	4.07%	4.62%	4.23%	4.63%
Common Equity to Total Capital	4.03%	2.50%	4.69%	1.34%	2.47%	6.41%	-0.10%	-0.69%	-0.06%	4.19%	6.69%
Debt to EBITDA	1.74	1.66	1.73	1.79	1.88	2.04	2.38	2.52	2.84	2.61	2.34
Net Debt to EBITDA	1.50	1.43	1.47	1.56	1.65	1.81	2.12	2.29	2.56	2.38	2.07
Long-Term Debt to EBITDA	1.38	1.52	1.62	1.68	1.76	1.96	2.37	2.51	2.82	2.60	2.33
Debt to NOPAT	2.49	2.42	2.57	2.67	2.89	2.96	4.09	4.38	4.13	4.10	3.64
Net Debt to NOPAT	2.16	2.08	2.19	2.33	2.53	2.63	3.64	3.98	3.73	3.74	3.23
Long-Term Debt to NOPAT	1.98	2.22	2.41	2.51	2.71	2.85	4.07	4.36	4.11	4.09	3.63
Altman Z-Score	6.39	6.58	6.76	6.59	6.32	6.08	5.79	5.84	5.73	5.96	5.67
Noncontrolling Interest Sharing Ratio	56.07%	45.30%	65.70%	92.60%	78.50%	42.71%	57.98%	88.09%	72.68%	43.16%	41.68%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.85	0.92	1.04	1.06	1.06	1.11	1.16	1.17	1.23	1.28	1.18
Quick Ratio	0.41	0.45	0.53	0.55	0.54	0.54	0.55	0.53	0.55	0.57	0.53
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	1,157	1,976	979	1,266	1,027	1,082	988	-213	-336	-1,347	126
Operating Cash Flow to CapEx	483.87%	689.67%	870.90%	846.15%	540.48%	576.65%	715.53%	392.39%	450.92%	304.52%	553.71%
Free Cash Flow to Firm to Interest Expense	17.53	10.45	42.57	57.56	17.71	0.00	0.00	-7.33	-6.23	-19.52	3.15
Operating Cash Flow to Interest Expense	9.09	6.71	50.74	45.00	11.74	0.00	0.00	24.90	13.61	9.75	24.23
Operating Cash Flow Less CapEx to Interest Expense	7.21	5.74	44.91	39.68	9.57	0.00	0.00	18.55	10.59	6.55	19.85
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.20	1.24	1.23	1.22	1.21	1.21	1.18	1.17	1.15	1.17	1.10
Accounts Receivable Turnover	11.28	12.94	12.23	11.48	11.61	12.59	12.75	11.87	11.75	12.83	12.45
Inventory Turnover	3.88	4.05	4.02	4.07	4.03	4.06	4.09	3.98	3.94	4.10	4.01
Fixed Asset Turnover	4.48	4.46	4.55	4.53	4.46	4.38	4.49	4.56	4.52	4.47	4.57
Accounts Payable Turnover	4.55	4.53	5.13	5.20	4.98	5.01	5.42	5.28	4.98	5.10	5.36
Days Sales Outstanding (DSO)	32.37	28.21	29.85	31.78	31.44	28.98	28.63	30.74	31.07	28.45	29.31
Days Inventory Outstanding (DIO)	94.04	90.12	90.87	89.73	90.68	89.96	89.27	91.78	92.60	89.04	90.98
Days Payable Outstanding (DPO)	80.24	80.52	71.08	70.25	73.35	72.92	67.40	69.13	73.25	71.64	68.04
Cash Conversion Cycle (CCC)	46.18	37.82	49.64	51.27	48.77	46.02	50.50	53.40	50.42	45.85	52.25
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	7,890	7,397	8,038	8,048	8,227	8,540	8,179	8,485	8,465	8,797	8,363
Invested Capital Turnover	2.48	2.52	2.48	2.42	2.37	2.24	2.31	2.31	2.30	2.22	2.20
Increase / (Decrease) in Invested Capital	-337	-1,143	-141	-437	-238	-257	-184	799	1,007	1,413	598
Enterprise Value (EV)	83,145	81,041	92,003	87,137	81,714	71,784	65,328	70,588	68,970	70,806	64,150
Market Capitalization	75,618	73,856	84,400	79,212	73,717	63,853	57,140	62,039	60,499	62,410	56,409
Book Value per Share	$0.45	$0.26	$0.53	$0.15	$0.28	$0.74	($0.01)	($0.08)	($0.01)	$0.48	$0.75
Tangible Book Value per Share	($5.86)	($5.89)	($5.86)	($6.11)	($6.03)	($5.69)	($6.29)	($6.43)	($6.38)	($5.83)	($6.16)
Total Capital	9,002	8,493	9,272	9,158	9,306	9,506	9,130	9,304	9,332	9,572	9,301
Total Debt	8,269	7,949	8,436	8,676	8,689	8,549	8,724	8,989	8,907	8,766	8,248
Total Long-Term Debt	6,571	7,289	7,909	8,146	8,151	8,219	8,690	8,954	8,870	8,741	8,219
Net Debt	7,157	6,853	7,202	7,566	7,610	7,583	7,773	8,170	8,040	7,991	7,310
Capital Expenditures (CapEx)	124	184	134	117	126	197	161	184	163	221	175
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-461	-878	-466	-284	-215	-98	-162	21	195	359	-123
Debt-free Net Working Capital (DFNWC)	651	218	768	826	864	868	789	840	1,062	1,134	815
Net Working Capital (NWC)	-1,047	-442	241	296	326	538	755	805	1,025	1,109	786
Net Nonoperating Expense (NNE)	94	56	62	62	60	65	57	52	257	23	42
Net Nonoperating Obligations (NNO)	7,157	6,853	7,202	7,566	7,610	7,583	7,773	8,170	8,040	7,991	7,310
Total Depreciation and Amortization (D&A)	148	148	150	157	150	150	144	145	128	135	134
Debt-free, Cash-free Net Working Capital to Revenue	-2.31%	-4.37%	-2.32%	-1.42%	-1.09%	-0.50%	-0.85%	0.11%	1.06%	2.00%	-0.69%
Debt-free Net Working Capital to Revenue	3.26%	1.08%	3.82%	4.13%	4.37%	4.46%	4.12%	4.50%	5.79%	6.31%	4.59%
Net Working Capital to Revenue	-5.25%	-2.20%	1.20%	1.48%	1.65%	2.77%	3.95%	4.31%	5.59%	6.17%	4.43%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.85	$0.91	$0.90	$0.89	$0.83	$0.86	$0.86	$0.61	$0.45	$0.00	$0.74
Adjusted Weighted Average Basic Shares Outstanding	810.42M	811.54M	817.01M	817.09M	820.44M	823.15M	823.37M	826.69M	829.57M	830.38M	835.21M
Adjusted Diluted Earnings per Share	$0.85	$0.89	$0.90	$0.89	$0.83	$0.86	$0.86	$0.60	$0.45	$0.01	$0.74
Adjusted Weighted Average Diluted Shares Outstanding	810.42M	811.54M	817.01M	817.09M	820.44M	823.15M	823.37M	826.69M	829.57M	830.38M	835.21M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	810.42M	811.54M	817.01M	817.09M	820.44M	823.15M	823.37M	826.69M	829.57M	830.38M	835.21M
Normalized Net Operating Profit after Tax (NOPAT)	820	833	838	829	789	825	804	586	671	141	724
Normalized NOPAT Margin	16.69%	16.84%	16.65%	16.40%	15.58%	16.66%	16.36%	12.16%	14.06%	3.05%	16.25%
Pre Tax Income Margin	19.41%	20.08%	19.59%	19.97%	19.09%	19.96%	19.45%	18.39%	11.76%	2.85%	20.02%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	15.21	5.63	46.30	49.64	17.67	0.00	0.00	33.59	11.39	2.71	23.30
NOPAT to Interest Expense	12.42	4.41	36.44	37.69	13.61	0.00	0.00	20.22	12.42	0.95	18.10
EBIT Less CapEx to Interest Expense	13.33	4.66	40.48	44.32	15.50	0.00	0.00	27.24	8.37	-0.49	18.93
NOPAT Less CapEx to Interest Expense	10.54	3.43	30.62	32.38	11.44	0.00	0.00	13.88	9.40	-2.25	13.73
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	59.13%	58.68%	58.74%	58.91%	63.29%	71.24%	99.42%	103.05%	95.78%	85.97%	80.59%
Augmented Payout Ratio	108.83%	115.71%	109.17%	111.06%	115.88%	117.19%	173.99%	166.89%	156.41%	152.47%	139.82%

Frequently Asked Questions About Colgate-Palmolive's Financials

When does Colgate-Palmolive's fiscal year end?

According to the most recent income statement we have on file, Colgate-Palmolive's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Colgate-Palmolive's net income changed over the last 9 years?

Colgate-Palmolive's net income appears to be on an upward trend, with a most recent value of $3.05 billion in 2024, rising from $1.55 billion in 2015. The previous period was $2.46 billion in 2023. See where experts think Colgate-Palmolive is headed by visiting Colgate-Palmolive's forecast page.

What is Colgate-Palmolive's operating income?

Colgate-Palmolive's total operating income in 2024 was $4.27 billion, based on the following breakdown:

Total Gross Profit: $12.16 billion
Total Operating Expenses: $7.89 billion

How has Colgate-Palmolive revenue changed over the last 9 years?

Over the last 9 years, Colgate-Palmolive's total revenue changed from $16.03 billion in 2015 to $20.10 billion in 2024, a change of 25.4%.

How much debt does Colgate-Palmolive have?

Colgate-Palmolive's total liabilities were at $15.50 billion at the end of 2024, a 0.4% increase from 2023, and a 29.4% increase since 2015.

How much cash does Colgate-Palmolive have?

In the past 9 years, Colgate-Palmolive's cash and equivalents has ranged from $726 million in 2018 to $1.54 billion in 2017, and is currently $1.10 billion as of their latest financial filing in 2024.

How has Colgate-Palmolive's book value per share changed over the last 9 years?

Over the last 9 years, Colgate-Palmolive's book value per share changed from -0.33 in 2015 to 0.26 in 2024, a change of -177.8%.

Related Companies

This page (NYSE:CL) was last updated on 5/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Colgate-Palmolive (CL) Financials

Frequently Asked Questions About Colgate-Palmolive's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Colgate-Palmolive (CL) Financials

Annual Income Statements for Colgate-Palmolive

Quarterly Income Statements for Colgate-Palmolive

Annual Cash Flow Statements for Colgate-Palmolive

Quarterly Cash Flow Statements for Colgate-Palmolive

Annual Balance Sheets for Colgate-Palmolive

Quarterly Balance Sheets for Colgate-Palmolive

Annual Metrics And Ratios for Colgate-Palmolive

Quarterly Metrics And Ratios for Colgate-Palmolive

Frequently Asked Questions About Colgate-Palmolive's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools